What is the recommended treatment for a patient with bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, with fluoroquinolones (moxifloxacin or gatifloxacin) or aminoglycosides (tobramycin) as first-line options. 1

Initial Assessment and Diagnosis

  • Bacterial conjunctivitis typically presents with purulent discharge, marked inflammation, and sometimes pain 1, 2
  • Obtain conjunctival cultures and Gram staining only in moderate to severe cases with copious purulent discharge, or when gonococcal infection is suspected 1, 3
  • Examine for swollen preauricular or submandibular lymph nodes, which indicate bacterial rather than viral etiology 2, 3

First-Line Antibiotic Selection

Fluoroquinolones are the preferred agents for moderate to severe bacterial conjunctivitis:

  • Moxifloxacin or gatifloxacin provide excellent coverage against common pathogens including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 2, 4, 5
  • Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) have superior gram-positive coverage, including some methicillin-resistant S. aureus strains 4
  • Gatifloxacin 0.5%: instill one drop every 2 hours while awake (up to 8 times) on Day 1, then one drop 2-4 times daily on Days 2-7 5

Aminoglycosides are effective alternatives:

  • Tobramycin provides broad-spectrum coverage and is particularly useful for rotating antibiotic classes to prevent resistance 2, 3, 4
  • Apply 4 times daily for 5-7 days 1, 4

For mild cases, choose the most convenient or least expensive option:

  • Polymyxin B/trimethoprim is effective for uncomplicated bacterial conjunctivitis 1, 4
  • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics when access is limited 1, 4

Special Situations Requiring Systemic Therapy

Gonococcal conjunctivitis requires immediate systemic antibiotics:

  • Adults: Ceftriaxone 1 g IM single dose PLUS azithromycin 1 g orally single dose (to cover concurrent chlamydial infection) 1
  • Add saline lavage to promote comfort and faster resolution 4
  • Topical antibiotics alone are completely inadequate 1, 4

Chlamydial conjunctivitis requires systemic therapy:

  • Adults: Azithromycin 1 g orally single dose OR doxycycline 100 mg orally twice daily for 7 days 1
  • Infants: Erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days 1, 4
  • Topical therapy provides no additional benefit beyond systemic treatment 4

MRSA conjunctivitis may require compounded vancomycin:

  • MRSA organisms are resistant to most commercially available topical antibiotics including fluoroquinolones and aminoglycosides 1, 4
  • Microbiology testing should guide therapy when MRSA is suspected 1

Critical Follow-Up Instructions

  • Instruct patients to return if no improvement occurs after 3-4 days of treatment 1, 2, 3, 4
  • At follow-up, perform visual acuity measurement and slit-lamp biomicroscopy 3, 4
  • For severe cases with corneal involvement or membranous conjunctivitis, schedule follow-up within 1 week 2

Important Pitfalls to Avoid

Do not use topical corticosteroids routinely:

  • Corticosteroids may prolong bacterial shedding and worsen infection 2, 3
  • Consider only for severe inflammation with marked chemosis or eyelid swelling, and only with close follow-up 2

Reserve fluoroquinolones appropriately:

  • Use fluoroquinolones for moderate to severe cases or suspected resistant organisms, particularly in contact lens wearers at higher risk for Pseudomonas infection 4
  • Overuse contributes to resistance development 4, 6, 7

Recognize when referral is mandatory:

  • Visual loss, moderate or severe pain, or severe purulent discharge 3, 4
  • Corneal involvement, conjunctival scarring, or lack of response to therapy 3, 4
  • Neonatal conjunctivitis requires immediate consultation 3

Infection Control Measures

  • Advise frequent hand washing and avoiding touching the eyes 2, 3, 4
  • Instruct patients not to share towels, pillowcases, or makeup 2
  • Patients should not wear contact lenses during treatment 5
  • Treatment reduces transmissibility and allows earlier return to school or work 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Streptococcal Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Infectious Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Limitations of current antibiotics for the treatment of bacterial conjunctivitis.

Optometry and vision science : official publication of the American Academy of Optometry, 2010

Research

[Bacterial conjunctivitis--diagnosis and therapy update].

Klinische Monatsblatter fur Augenheilkunde, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.